SEB S.A./ FR0000121709 /
2024-06-21 7:57:35 AM | Chg. +1.5000 | Volume | Bid10:00:04 PM | Ask10:00:04 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
105.0000EUR | +1.45% | - Turnover: - |
103.5000Bid Size: 39 | 104.7000Ask Size: 39 | 5.76 bill.EUR | 2.52% | 14.85 |
GlobeNewswire
01-29
Journal of the American Academy of Dermatology Publishes ZORYVE (roflumilast) Foam, 0.3% Results for...
GlobeNewswire
01-22
ZORYVE® (roflumilast) Topical Foam, 0.3%, for the Treatment of Seborrheic Dermatitis Launches in the...
GlobeNewswire
01-19
CIP launches new company dedicated to developing energy island projects globally
GlobeNewswire
2023-09-25
New Campaign from Arcutis Aims to Educate, Raise Awareness, and Provide Encouragement for Those Livi...
Newsfile Corp
2022-10-10
GaiaLens Unveils its ESG Reporting Capability as Part of its Data-Driven, AI-Based ESG Analytics Pla...
GlobeNewswire
2022-01-27
F2 Strategy’s 2022 Outlook Report Shows Cryptocurrency Adoption, Data Aggregation and Operations Aut...
GlobeNewswire
2021-12-22
MicroEJ and Groupe SEB, leader in small domestic appliances, announce their collaboration in the dev...
GlobeNewswire
2021-11-03
Bestselling 'Beauty of Horror' Creator Alan Robert Launches Whitelist for 'Monster Chompers' NFT Col...
GlobeNewswire
2021-09-16
F2 Strategy Trailblazes WealthTech Space with Record Growth of Outsourced CTO and Consulting Service...
GlobeNewswire
2021-07-12
Arcutis Announces First Patient Enrolled in Phase 3 Clinical Trial of Topical Roflumilast Foam (ARQ-...
GlobeNewswire
2021-05-25
Sinch AB (publ): Sinch completes a directed new share issue of 7,232,077 shares, raising approximate...
GlobeNewswire
2021-05-24
Sinch AB (publ): Sinch evaluates the conditions to carry out a directed new share issue
GlobeNewswire
2021-04-07
SEB Partners With Quebec Based Gesticonnect to Digitize Benefits for Emerging Businesses in Quebec
GlobeNewswire
2020-06-18
ELAN Class Action Deadline: Barbuto & Johansson, P.A. Reminds Elanco Animal Health, Inc. Shareholder...